On October 31, 2008, Caraco Pharmaceutical Laboratories, Ltd. received a warning letter from the FDA. The letter was issued as a follow up to the last FDA inspection of the Company's manufacturing facility in Detroit, Michigan which was initiated in May 2008. As previously disclosed, a Form 483 notice was issued in June 2008 following this inspection.
The details can be read here.
No comments:
Post a Comment